Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Deoxyribose phosphorothioate (5'-tct-ccc-agc-gtg-cgc-cat-3')

EU orphan designation number: EU/3/01/063
Active ingredient: Deoxyribose phosphorothioate (5'-tct-ccc-agc-gtg-cgc-cat-3')
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Voisin Consulting S.A.R.L.
3 rue des Longs Prés, 92100 Boulogne-Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Orphan designation EMEA/OD/025/01 (2001)3574 of 20/11/2001
07/01/2003 Transfer of orphan designation EMEA/OD/025/01/T/01 (2002)5515 of 06/01/2003
28/07/2005 Transfer of orphan designation EMEA/OD/025/01/T/01 (2005)2941 of 26/07/2005
01/12/2005 Change of name and/or address of sponsor
15/03/2013 Removal of orphan designation from Community Register